These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20070701)

  • 1. Epstein-barr virus and posttransplant lymphoproliferative disorder in solid organ transplant recipients.
    Allen U; Preiksaitis J;
    Am J Transplant; 2009 Dec; 9 Suppl 4():S87-96. PubMed ID: 20070701
    [No Abstract]   [Full Text] [Related]  

  • 2. Epstein-Barr virus and posttransplant lymphoproliferative disorder in solid organ transplantation.
    Allen UD; Preiksaitis JK;
    Am J Transplant; 2013 Mar; 13 Suppl 4():107-20. PubMed ID: 23465004
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of posttransplant lymphoproliferative disorders following solid organ transplant: an update.
    Dierickx D; Tousseyn T; De Wolf-Peeters C; Pirenne J; Verhoef G
    Leuk Lymphoma; 2011 Jun; 52(6):950-61. PubMed ID: 21338285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posttransplant lymphoproliferative diseases.
    Gross TG; Savoldo B; Punnett A
    Pediatr Clin North Am; 2010 Apr; 57(2):481-503, table of contents. PubMed ID: 20371048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Epstein-Barr virus-induced post-transplant lymphoproliferative disease in recipients of solid organ transplantation.
    Green M
    Am J Transplant; 2001 Jul; 1(2):103-8. PubMed ID: 12099356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus lymphoproliferative disease after solid organ transplantation.
    Prockop SE; Vatsayan A
    Cytotherapy; 2017 Nov; 19(11):1270-1283. PubMed ID: 28965834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttransplant lymphoproliferative disorder after liver and kidney transplant.
    Akar Özkan E; Özdemir BH; Deniz EE; Tunca MZ; Haberal M
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():142-8. PubMed ID: 24635813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Epstein-Barr virus-associated posttransplant lymphoproliferative disorders.
    Gross TG
    J Pediatr Hematol Oncol; 2001 Jan; 23(1):7-9. PubMed ID: 11196278
    [No Abstract]   [Full Text] [Related]  

  • 9. Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting.
    Paya CV; Fung JJ; Nalesnik MA; Kieff E; Green M; Gores G; Habermann TM; Wiesner PH; Swinnen JL; Woodle ES; Bromberg JS
    Transplantation; 1999 Nov; 68(10):1517-25. PubMed ID: 10589949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and virologic outcomes in high-risk adult Epstein-Barr virus mismatched organ transplant recipients.
    Kumar D; Patil N; Husain S; Chaparro C; Bhat M; Kim SJ; Humar A
    Clin Transplant; 2017 Jul; 31(7):. PubMed ID: 28489256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Changing Epidemiology of Posttransplant Lymphoproliferative Disorder in Adult Solid Organ Transplant Recipients Over 30 Years: A Single-center Experience.
    Peters AC; Akinwumi MS; Cervera C; Mabilangan C; Ghosh S; Lai R; Iafolla M; Doucette K; Preiksaitis JK
    Transplantation; 2018 Sep; 102(9):1553-1562. PubMed ID: 29485513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients.
    San-Juan R; Comoli P; Caillard S; Moulin B; Hirsch HH; Meylan P;
    Clin Microbiol Infect; 2014 Sep; 20 Suppl 7():109-18. PubMed ID: 24475976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
    Allen UD; Preiksaitis JK;
    Clin Transplant; 2019 Sep; 33(9):e13652. PubMed ID: 31230381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of Epstein-Barr virus associated post-transplant lymphoproliferative disorders in pediatric solid-organ transplant recipients.
    Green M; Michaels MG; Webber SA; Rowe D; Reyes J
    Pediatr Transplant; 1999 Nov; 3(4):271-81. PubMed ID: 10562971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttransplant lymphoproliferative disorder.
    Everly MJ; Bloom RD; Tsai DE; Trofe J
    Ann Pharmacother; 2007 Nov; 41(11):1850-8. PubMed ID: 17940127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of Epstein-Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation.
    Lim WH; Russ GR; Coates PT
    Nephrology (Carlton); 2006 Aug; 11(4):355-66. PubMed ID: 16889577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Cytomegalovirus in the Development of Posttransplant Lymphoproliferative Disorders With or Without Epstein-Barr Virus Infection.
    Namayandeh M; Jamalidoust M; Pouladfar G; Zare M; Ziyaeyan M
    Exp Clin Transplant; 2022 Aug; 20(8):757-761. PubMed ID: 35037609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines.
    Styczynski J; van der Velden W; Fox CP; Engelhard D; de la Camara R; Cordonnier C; Ljungman P;
    Haematologica; 2016 Jul; 101(7):803-11. PubMed ID: 27365460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of results in posttransplant lymphoproliferative disorder.
    Singer LG; Theodore J; Gould MK
    Chest; 2000 Oct; 118(4):1227-8. PubMed ID: 11035707
    [No Abstract]   [Full Text] [Related]  

  • 20. New approaches to posttransplant lymphoproliferative disorder (PTLD).
    Porcu P
    Clin Adv Hematol Oncol; 2005 Jan; 3(1):24-6. PubMed ID: 16166963
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.